• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏直视手术后植入心脏植入式电子设备的患者的发病率、适应证、风险因素和生存率。

Incidence, indications, risk factors, and survival of patients undergoing cardiac implantable electronic device implantation after open heart surgery.

机构信息

Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Cleveland Clinic, Sydell and Arnold Miller Heart & Vascular Institute, 9500 Euclid Avenue, Mail Code J3, Cleveland, OH 44195, USA.

Department of Quantitative Health Sciences, Cleveland Clinic, Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

出版信息

Europace. 2017 Aug 1;19(8):1335-1342. doi: 10.1093/europace/euw234.

DOI:10.1093/europace/euw234
PMID:27738074
Abstract

AIMS

The incidence, indications, and risk factors for cardiac implantable electronic device (CIED) implantation after cardiac surgery in an era with an aging population are not well described. There are limited data about the survival of these patients compared with a non-device group. We aimed to evaluate the incidence, indications, and risk factors for postoperative CIED implantation. We also assessed survival of these patients compared with a non-device group.

METHODS

We included all patients without prior CIED implantation who underwent cardiac surgery at our institution from 1996 to 2008. Characteristics associated with CIED implantation were identified by multivariable logistic regression. A propensity model was constructed to compare survival.

RESULTS

A total of 39 546 patients were included in the study of which 1608 patients (4.1%) underwent postoperative CIED implantation. Conduction disease accounted for most devices, but 371 patients underwent CIED implantation for secondary prevention of ventricular arrhythmias. Risk factors associated with implantation included older age, valvular disease, atrial fibrillation, and prior surgery. The propensity-adjusted risk of early death (within 1 year) was significantly less in the device group (hazard ratio [HR] 0.38; 95% confidence interval [CI] 0.22-0.65; P = 0.0004). However, the propensity-adjusted risk of late death was significantly greater in the device group (HR 1.3; 95% CI 1.2-1.5; P = <0.0001).

CONCLUSION

Despite an aging population, the incidence of CIED implantation after cardiac surgery remains low and varies by the type of operation. Follow-up suggests increased early survival but decreased late survival in patients who undergo CIED implantation compared with a non-device group.

摘要

目的

在人口老龄化的时代,心脏手术后植入心脏植入式电子设备(CIED)的发生率、适应证和危险因素尚未得到充分描述。与非设备组相比,这些患者的生存数据有限。我们旨在评估心脏手术后 CIED 植入的发生率、适应证和危险因素。我们还评估了这些患者与非设备组相比的生存情况。

方法

我们纳入了 1996 年至 2008 年期间在我院行心脏手术且无先前 CIED 植入史的所有患者。通过多变量逻辑回归确定与 CIED 植入相关的特征。构建倾向评分模型以比较生存情况。

结果

共纳入 39546 例患者,其中 1608 例(4.1%)患者术后植入了 CIED。传导疾病是最常见的植入原因,但 371 例患者植入 CIED 是为了二级预防室性心律失常。与植入相关的危险因素包括年龄较大、瓣膜疾病、心房颤动和既往手术。设备组早期死亡(1 年内)的风险显著降低(风险比 [HR] 0.38;95%置信区间 [CI] 0.22-0.65;P = 0.0004)。然而,设备组晚期死亡的风险显著增加(HR 1.3;95% CI 1.2-1.5;P <0.0001)。

结论

尽管人口老龄化,但心脏手术后 CIED 植入的发生率仍然较低,且因手术类型而异。随访表明,与非设备组相比,植入 CIED 的患者早期生存率提高,但晚期生存率降低。

相似文献

1
Incidence, indications, risk factors, and survival of patients undergoing cardiac implantable electronic device implantation after open heart surgery.心脏直视手术后植入心脏植入式电子设备的患者的发病率、适应证、风险因素和生存率。
Europace. 2017 Aug 1;19(8):1335-1342. doi: 10.1093/europace/euw234.
2
Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.慢性肾脏病患者植入式心脏复律除颤器:倾向匹配的死亡率分析
Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1119-27. doi: 10.2215/CJN.11121114. Epub 2015 Jun 25.
3
Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.在一个大型全国队列中,植入起搏器、除颤器和心脏再同步治疗设备后女性与男性的生存率比较
J Am Heart Assoc. 2017 May 10;6(5):e005031. doi: 10.1161/JAHA.116.005031.
4
Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study.感染性心内膜炎与心脏植入式电子设备植入术后死亡风险:一项全国性队列研究。
Europace. 2017 Jun 1;19(6):1007-1014. doi: 10.1093/europace/euw404.
5
Impact of Improved Left Ventricular Systolic Function on the Recurrence of Ventricular Arrhythmia in Heart Failure Patients With an Implantable Cardioverter-Defibrillator.左心室收缩功能改善对植入式心脏复律除颤器治疗的心力衰竭患者室性心律失常复发的影响
J Cardiovasc Electrophysiol. 2016 Oct;27(10):1191-1198. doi: 10.1111/jce.13037. Epub 2016 Jul 15.
6
Outcomes of lead extraction without subsequent device reimplantation.无后续器械再植入的 Lead 提取术的结果。
Europace. 2017 Sep 1;19(9):1527-1534. doi: 10.1093/europace/euw184.
7
Implantable cardiac electronic device therapy for patients with a systemic right ventricle.植入式心脏电子设备治疗具有全身性右心室的患者。
Heart. 2020 Jul;106(14):1052-1058. doi: 10.1136/heartjnl-2019-316202. Epub 2020 Apr 8.
8
Complications of permanent cardiac pacing in patients with persistent left superior vena cava.永存左上腔静脉患者永久性心脏起搏的并发症
Cardiol J. 2014;21(2):128-37. doi: 10.5603/CJ.a2014.0006. Epub 2014 Feb 14.
9
Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.由于起搏诱导性心肌病而升级为心脏再同步治疗的患者发生危及生命的室性心律失常的风险较低:一项长期死因分析。
Europace. 2018 Jan 1;20(1):89-96. doi: 10.1093/europace/euw321.
10
Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.接受心脏植入式电子设备植入的心房颤动患者的口服抗凝管理。
Clin Cardiol. 2017 Sep;40(9):746-751. doi: 10.1002/clc.22726. Epub 2017 May 19.

引用本文的文献

1
Permanent pacemaker implantation following mitral valve surgery. State-of-the-art scoping review.二尖瓣手术后永久性起搏器植入。最新技术范围综述。
Eur J Cardiothorac Surg. 2025 Jul 1;67(7). doi: 10.1093/ejcts/ezaf210.
2
Implications of pacemaker implantation after aortic valve surgery for endocarditis: a nationwide study†.主动脉瓣置换术后植入起搏器对心内膜炎的影响:一项全国性研究†
Eur J Cardiothorac Surg. 2025 Mar 28;67(4). doi: 10.1093/ejcts/ezaf125.
3
How robust are recommended waiting times to pacing after cardiac surgery that are derived from observational data?
基于观察数据推导的心脏手术后推荐起搏等待时间有多可靠?
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad238.
4
Cardiac pacing and lead devices management: 25 years of research at EP Europace journal.心脏起搏和导联设备管理:EP Europace 杂志 25 年的研究成果。
Europace. 2023 Aug 25;25(8). doi: 10.1093/europace/euad202.
5
Permanent pacemaker placement following valve surgery is not independently associated with worse outcomes.瓣膜手术后植入永久性起搏器与更差的预后并无独立相关性。
JTCVS Open. 2021 Jun 16;7:157-164. doi: 10.1016/j.xjon.2021.06.005. eCollection 2021 Sep.
6
Permanent pacemaker implantation after On-X surgical aortic valve replacement: SWEDEHEART observational study.经 On-X 外科主动脉瓣置换术后行永久性心脏起搏器植入:SWEDEHEART 观察性研究。
BMJ Open. 2021 Nov 18;11(11):e047962. doi: 10.1136/bmjopen-2020-047962.
7
Long-term Outcomes Associated With Permanent Pacemaker Implantation After Surgical Aortic Valve Replacement.主动脉瓣置换术后永久性心脏起搏器植入的长期预后。
JAMA Netw Open. 2021 Jul 1;4(7):e2116564. doi: 10.1001/jamanetworkopen.2021.16564.
8
Comparative Surgical Outcomes of Prosthetic and Native Valve Endocarditis.人工瓣膜与自体瓣膜心内膜炎的手术疗效比较
Korean Circ J. 2021 Jun;51(6):504-514. doi: 10.4070/kcj.2020.0448.
9
Surgical Techniques, Complications, and Long-Term Health Effects of Cardiac Implantable Electronic Devices.心脏植入式电子设备的手术技术、并发症及长期健康影响
Cureus. 2021 Jan 30;13(1):e13001. doi: 10.7759/cureus.13001.
10
Incidence and Risk Factors for Permanent Pacemaker Implantation Following Mitral or Aortic Valve Surgery.二尖瓣或主动脉瓣手术后永久性心脏起搏器植入的发生率和危险因素。
J Am Coll Cardiol. 2019 Nov 26;74(21):2607-2620. doi: 10.1016/j.jacc.2019.08.1064.